Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17425952rdf:typepubmed:Citationlld:pubmed
pubmed-article:17425952lifeskim:mentionsumls-concept:C0006142lld:lifeskim
pubmed-article:17425952lifeskim:mentionsumls-concept:C1516213lld:lifeskim
pubmed-article:17425952lifeskim:mentionsumls-concept:C0027996lld:lifeskim
pubmed-article:17425952lifeskim:mentionsumls-concept:C0035527lld:lifeskim
pubmed-article:17425952lifeskim:mentionsumls-concept:C0056077lld:lifeskim
pubmed-article:17425952lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:17425952lifeskim:mentionsumls-concept:C0232970lld:lifeskim
pubmed-article:17425952lifeskim:mentionsumls-concept:C1561577lld:lifeskim
pubmed-article:17425952lifeskim:mentionsumls-concept:C1514811lld:lifeskim
pubmed-article:17425952lifeskim:mentionsumls-concept:C1706462lld:lifeskim
pubmed-article:17425952lifeskim:mentionsumls-concept:C0443602lld:lifeskim
pubmed-article:17425952pubmed:issue9-10lld:pubmed
pubmed-article:17425952pubmed:dateCreated2007-6-4lld:pubmed
pubmed-article:17425952pubmed:abstractTextTamoxifen (TAM), a non-steroidal anti-estrogen that is widely used in adjuvant therapy for all stages of breast carcinomas and in chemoprevention of high-risk group. The hepatic estrogenic effect of TAM induces hypertriglyceridemia by reduced activity of lipolytic enzymes (LPL) on triglycerides. Coenzyme Q10 (Co Q10), riboflavin and niacin are proved to be potent antioxidant and protective agents against many diseases including cancer and cardiovascular diseases (CVD). In this context, the objective of the study is to find the effect of the combined modality of Co Q10 (100 mg), riboflavin (10 mg) and niacin (50 mg) with TAM (10 mg twice a day) on serum lipids and lipoprotein levels in postmenopausal women with breast cancer.lld:pubmed
pubmed-article:17425952pubmed:languageenglld:pubmed
pubmed-article:17425952pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17425952pubmed:citationSubsetIMlld:pubmed
pubmed-article:17425952pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17425952pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17425952pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17425952pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17425952pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17425952pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17425952pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17425952pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17425952pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17425952pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17425952pubmed:statusMEDLINElld:pubmed
pubmed-article:17425952pubmed:monthJunlld:pubmed
pubmed-article:17425952pubmed:issn0009-9120lld:pubmed
pubmed-article:17425952pubmed:authorpubmed-author:SachdanandamP...lld:pubmed
pubmed-article:17425952pubmed:authorpubmed-author:PremkumarVumm...lld:pubmed
pubmed-article:17425952pubmed:authorpubmed-author:YuvarajSriniv...lld:pubmed
pubmed-article:17425952pubmed:authorpubmed-author:Vijayasarathy...lld:pubmed
pubmed-article:17425952pubmed:authorpubmed-author:GangadaranSit...lld:pubmed
pubmed-article:17425952pubmed:issnTypePrintlld:pubmed
pubmed-article:17425952pubmed:volume40lld:pubmed
pubmed-article:17425952pubmed:ownerNLMlld:pubmed
pubmed-article:17425952pubmed:authorsCompleteYlld:pubmed
pubmed-article:17425952pubmed:pagination623-8lld:pubmed
pubmed-article:17425952pubmed:meshHeadingpubmed-meshheading:17425952...lld:pubmed
pubmed-article:17425952pubmed:meshHeadingpubmed-meshheading:17425952...lld:pubmed
pubmed-article:17425952pubmed:meshHeadingpubmed-meshheading:17425952...lld:pubmed
pubmed-article:17425952pubmed:meshHeadingpubmed-meshheading:17425952...lld:pubmed
pubmed-article:17425952pubmed:meshHeadingpubmed-meshheading:17425952...lld:pubmed
pubmed-article:17425952pubmed:meshHeadingpubmed-meshheading:17425952...lld:pubmed
pubmed-article:17425952pubmed:meshHeadingpubmed-meshheading:17425952...lld:pubmed
pubmed-article:17425952pubmed:meshHeadingpubmed-meshheading:17425952...lld:pubmed
pubmed-article:17425952pubmed:meshHeadingpubmed-meshheading:17425952...lld:pubmed
pubmed-article:17425952pubmed:meshHeadingpubmed-meshheading:17425952...lld:pubmed
pubmed-article:17425952pubmed:meshHeadingpubmed-meshheading:17425952...lld:pubmed
pubmed-article:17425952pubmed:meshHeadingpubmed-meshheading:17425952...lld:pubmed
pubmed-article:17425952pubmed:meshHeadingpubmed-meshheading:17425952...lld:pubmed
pubmed-article:17425952pubmed:meshHeadingpubmed-meshheading:17425952...lld:pubmed
pubmed-article:17425952pubmed:meshHeadingpubmed-meshheading:17425952...lld:pubmed
pubmed-article:17425952pubmed:meshHeadingpubmed-meshheading:17425952...lld:pubmed
pubmed-article:17425952pubmed:meshHeadingpubmed-meshheading:17425952...lld:pubmed
pubmed-article:17425952pubmed:meshHeadingpubmed-meshheading:17425952...lld:pubmed
pubmed-article:17425952pubmed:meshHeadingpubmed-meshheading:17425952...lld:pubmed
pubmed-article:17425952pubmed:year2007lld:pubmed
pubmed-article:17425952pubmed:articleTitleAmeliorating effect of coenzyme Q10, riboflavin and niacin in tamoxifen-treated postmenopausal breast cancer patients with special reference to lipids and lipoproteins.lld:pubmed
pubmed-article:17425952pubmed:affiliationDepartment of Medical Biochemistry, University of Madras, Taramani Campus, Chennai - 600 113, Tamil Nadu, India.lld:pubmed
pubmed-article:17425952pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17425952lld:pubmed